Original Research
Published on 11 Oct 2022
Small airway dysfunction in idiopathic pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1025814
- 3,032 views
- 9 citations
Type at least 3 characters
631 articles
Original Research
Published on 11 Oct 2022
In vitro neutrophil migration is associated with inhaled corticosteroid treatment and serum cytokines in pediatric asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1021317
- 3,724 views
- 1 citation
Review
Published on 11 Oct 2022
Gene therapy for cystic fibrosis: Challenges and prospects
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1015926
- 37,342 views
- 30 citations
Review
Published on 10 Oct 2022
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.987816
- 8,731 views
- 11 citations
Original Research
Published on 06 Oct 2022
Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.996046
- 4,171 views
- 1 citation
Review
Published on 05 Oct 2022
Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.966637
- 5,073 views
- 1 citation
Original Research
Published on 03 Oct 2022
A-Kinase Anchor Protein 1 deficiency causes mitochondrial dysfunction in mouse model of hyperoxia induced acute lung injury
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.980723
- 4,876 views
- 14 citations
Original Research
Published on 30 Sep 2022
The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.985223
- 7,010 views
- 18 citations
Original Research
Published on 29 Sep 2022
Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.988153
- 3,157 views
- 4 citations
Original Research
Published on 28 Sep 2022
Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.950035
- 3,053 views
- 7 citations
Original Research
Published on 28 Sep 2022
L-cysteine methyl ester overcomes the deleterious effects of morphine on ventilatory parameters and arterial blood-gas chemistry in unanesthetized rats
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.968378
- 3,161 views
- 16 citations
Original Research
Published on 27 Sep 2022
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.935370
- 4,377 views
- 1 citation
Original Research
Published on 27 Sep 2022
Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.956549
- 3,141 views
Original Research
Published on 26 Sep 2022
Vegetable glycerin e-cigarette aerosols cause airway inflammation and ion channel dysfunction
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1012723
- 12,763 views
- 28 citations
Opinion
Published on 23 Sep 2022
The application of antimicrobials in VAP patients requiring ECMO supportive treatment
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.918175
- 2,398 views
Review
Published on 16 Sep 2022
Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.978151
- 4,202 views
- 8 citations